Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View

Dr. Daniel Pollyea

Leukemia · CU Anschutz Medical Campus

View

Dr. Jessica Altman

Leukemia · Northwestern Medicine

View

Dr. Shella Saint Fleur-Lominy

Leukemia · UMSOM

View

Dr. Azra Raza

Leukemia · CUIMC

View

Dr. Molly Imgruet

Leukemia · Stanford

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JKDr. Justin Kaner

    Dr. Justin Kaner

    Hematology & Oncology · Leukemia
    NewYork–Presbyterian Hospital
    justink

    Research

    Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasms.

    2026

    Via Leukemia

    Research

    Colonization with extended-spectrum and AmpC β-lactamase-producing Enterobacterales and bacteremia risk in patients with acute leukemia who receive induction chemotherapy without fluoroquinolone prophylaxis.

    2026

    Via Antimicrobial Agents and Chemotherapy

    Research

    Revumenib: a new era in acute leukemia treatment.

    2025

    Via Trends in Cancer

    Research

    Single-cell spatial mapping reveals dynamic bone marrow microarchitectural alterations and enhances clinical diagnostics in MDS.

    2025

    Via bioRxiv (Preprint)

    Research

    Wild-type p53 overexpression in-mutated acute myeloid leukemia: potential implications for disease biology and therapy response.

    2025

    Via Haematologica

    Research

    Current landscape of CD3 bispecific antibodies in hematologic malignancies.

    2024

    Via Trends in Cancer

    Research

    Detection of Hybrid Fusion Transcripts, Aberrant Transcript Expression, and Specific Single Nucleotide Variants in Acute Leukemia and Myeloid Disorders with Recurrent Gene Rearrangements.

    2023

    Via Pathobiology

    Research

    Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia.

    2021

    Via NPJ Precision Oncology

    Research

    Chemical probes and methods for single-cell detection and quantification of epichaperomes in hematologic malignancies.

    2020

    Via Methods in Enzymology

    Research

    Clonal Hematopoiesis and Premalignant Diseases.

    2020

    Via Cold Spring Harbor Perspectives in Medicine

    Research

    HIV portends a poor prognosis in myelodysplastic syndromes.

    2019

    Via Leukemia & Lymphoma

    Research

    Risk factors and prognosis of ovarian vein thrombosis.

    2017

    Via Blood Coagulation & Fibrinolysis

    Research

    Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis.

    2016

    Via Oncotarget

    Research

    Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer.

    2016

    Via The Journal of Biological Chemistry

    Research

    Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.

    2015

    Via Immunotherapy